Abstract
Islet transplantation is emerging as an attractive alternative to solitary pancreas transplantation for a highly select group of patients with severe, labile forms of Type 1 diabetes that had previously tried and failed on intensive insulin therapy. The year 2000 marked a dramatic shift in clinical success with the introduction of the so-called ‘Edmonton Protocol’, which built upon many years of intensive research and extensive collaborations between islet groups worldwide (1,2).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
